Understanding the mechanism by which loss of CFTR function leads to an imbalance in ceramide species, how this imbalance affects the disease state, and how to correct the imbalance, are important future steps toward developing new alternative treatments for CF. This evidence concerns the gene CFTR and cystic fibrosis.